Published in Clin Exp Immunol on April 01, 1978
Hyperosmolar triggering of histamine release from human basophils. J Clin Invest (1981) 1.21
Adverse reactions to radiographic contrast material. West J Med (1980) 0.80
Increased in vitro histamine release by radiographic contrast media in patients with history of incompatibility. Clin Exp Immunol (1978) 0.77
The potential utility of iodinated contrast media (ICM) skin testing in patients with ICM hypersensitivity. J Korean Med Sci (2015) 0.75
Staining of tissue sections for electron microscopy with heavy metals. J Biophys Biochem Cytol (1958) 74.43
A SIMPLIFIED LEAD CITRATE STAIN FOR USE IN ELECTRON MICROSCOPY. J Cell Biol (1965) 37.37
Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med (1955) 13.98
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med (1972) 5.38
Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine. Clin Chim Acta (1972) 2.92
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry (1976) 2.89
Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med (1975) 2.31
Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen. J Exp Med (1970) 2.22
The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens. Immunochemistry (1971) 2.16
Adverse reactions to contrast agents. Scope of problem. Invest Radiol (1971) 1.95
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. J Clin Invest (1973) 1.64
Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J Immunol (1977) 1.63
In vitro studies of human reaginic allergy. Adv Immunol (1968) 1.50
The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187. J Immunol (1975) 1.45
Immunological induction of increased vascular permeability. I. A rabbit passive cutaneous anaphylactic reaction requiring complement, platelets, and neutrophils. J Exp Med (1969) 1.44
Studies on the mechanism of hypersensitivity phenomena. XI. The effect of normal human serum on the release of histamine from human leukocytes by ragweed pollen antigen. J Immunol (1966) 1.41
Cutaneous responses to human C 3 anaphylatoxin in man. Clin Exp Immunol (1972) 1.39
Immune reactions of human blood platelets. I. A comparative study on the effects on platelets of heterologous antiplatet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin. Thromb Diath Haemorrh (1968) 1.33
Intravascular platelet aggregation in the heart induced by norepinephrine. Microscopic studies. Circulation (1972) 1.23
Reactions associated with intravenous urography: historical and statistical review. Radiology (1958) 1.15
An experimental basis for histamine release in contrast material reactions. Radiology (1974) 1.13
Histamine release in man. Agents Actions (1975) 1.11
Activation of the alternative pathway of the complement system by radiographic contrast media. J Immunol (1976) 1.11
Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction. J Immunol (1976) 1.10
Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus. J Immunol (1976) 1.06
The antigen-induced degranulation of basophil leukocytes from atopic subjects studied by electron microscopy. Lab Invest (1977) 0.99
Mechanism of complement activation by radiographic contrast media. Clin Exp Immunol (1977) 0.94
Interaction of rabbit platelets and leukocytes in the release of histamine. Electron microscopic observations. Am J Pathol (1971) 0.92
Electron microscopic study of human basophils. Blood (1967) 0.90
The administration of radiographic contrast media to patients with a history of a previous reaction. J Allergy Clin Immunol (1975) 0.87
Urographic contrast media reactions and anxiety. Radiology (1974) 0.87
Contrast media as histamine liberators. VI. Arterial plasma histamine and hemodynamic responses following angiocardiography in man with 75 per cent hypaque. Invest Radiol (1973) 0.86
Activation of serum complement by contrast media. Invest Radiol (1976) 0.86
The significance of protein binding of contrast media in roentgen diagnosis. Am J Roentgenol Radium Ther Nucl Med (1962) 0.85
The allergic theory of radiocontrast agent toxicity: demonstration of antibody activity in sera of patients suffering major radiocontrast agent reactions. Invest Radiol (1977) 0.85
Contrast media as histamine liberators in man. Agents Actions (1974) 0.83
Degranulation mechanisms in human leukemic basophils. Clin Immunol Immunopathol (1976) 0.83
A study of the ultrastructure of human basophil leukocytes. Lab Invest (1974) 0.81
Improved compatibility of ALG therapy by application of aggregate free globulin. Int Arch Allergy Appl Immunol (1976) 0.79
Platelet and leukocyte aggregation associated with antigenic leukocyte histamine release. Lab Invest (1974) 0.79
Effect of contrast agents on platelet aggregation and 14C-serotonin release. N Engl J Med (1974) 0.79
Contrast media as histamine liberators. IV. In vitro mast cell histamine release by methylglucamine salts. Invest Radiol (1971) 0.79
Reaction to radiographic contrast agents: new developments in etiology. Ann Allergy (1976) 0.78
Specific interaction of HLA antibodies (eluates) with washed platelets. Br J Haematol (1977) 0.77
Measurement of histamine, complement components and immune complexes during patient reactions to iodinated contrast material. Invest Radiol (1976) 0.77
Histamine release from human leucocytes. A serum factor necessary for the induction of histamine release and desensitization by protein A. Immunology (1977) 0.77
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. Arthritis Rheum (1979) 13.72
Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med (1972) 11.51
Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol (1982) 9.73
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 7.40
Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A (1980) 7.33
Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science (1968) 5.88
Characterization of T7-specific ribonucleic acid polymerase. 1. General properties of the enzymatic reaction and the template specificity of the enzyme. J Biol Chem (1973) 5.42
Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum (1976) 5.33
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med (1975) 5.00
puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosophila. Genes Dev (1998) 4.64
Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest (1975) 4.62
Autoantibody to a nuclear antigen in proliferating cells. J Immunol (1978) 4.36
Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome. Arthritis Rheum (1976) 4.02
Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med (1991) 4.02
Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92
Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum (1980) 3.87
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem (1985) 3.60
Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58
Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (1997) 3.48
Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies. Exp Cell Res (1991) 3.44
Molecular analysis of the membrane attack mechanism of complement. J Exp Med (1972) 3.35
Characterization of T7-specific ribonucleic acid polymerase. II. Inhibitors of the enzyme and their application to the study of the enzymatic reaction. J Biol Chem (1973) 3.32
Monoclonal autoantibody from a (New Zealand black x New Zealand white)F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle. Arthritis Rheum (1987) 3.09
Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem (1979) 2.99
A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med (1988) 2.98
A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med (1981) 2.82
Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res (1986) 2.74
Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J Lab Clin Med (1967) 2.71
Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum (1995) 2.67
Reproducibility of patch tests. J Am Acad Dermatol (1989) 2.65
Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet (1977) 2.60
Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med (1978) 2.52
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med (1970) 2.41
A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med (1999) 2.36
Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol (1982) 2.29
Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest (1991) 2.28
Antinucleolar antibodies in human sera. J Immunol (1973) 2.28
Association between the nucleolus and the coiled body. J Struct Biol (1991) 2.18
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy (2008) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res (1987) 2.13
Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc Natl Acad Sci U S A (1993) 2.13
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Manifestation of atopy is not related to patient's month of birth. Allergy (1993) 2.11
Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med (1980) 2.10
Integration and transcription of mouse mammary tumor virus DNA in rat hepatoma cells. Proc Natl Acad Sci U S A (1979) 2.08
An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum (1966) 2.07
Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods (1988) 2.07
Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology (2000) 2.04
Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest (1987) 1.99
An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest (1967) 1.99
Detection of a nucleolar 7-2 ribonucleoprotein and a cytoplasmic 8-2 ribonucleoprotein with autoantibodies from patients with scleroderma. J Biol Chem (1983) 1.98
Distribution of kinetochore (centromere) antigen in mammalian cell nuclei. J Cell Biol (1981) 1.97
Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence. Arthritis Rheum (1976) 1.92
Isolation and characterization of nuclear ribonucleoprotein complexes using human anti-nuclear ribonucleoprotein antibodies. J Biol Chem (1979) 1.92
Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus. Exp Cell Res (1988) 1.87
Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest (1978) 1.86
Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med (1987) 1.84
UV-induced skin changes due to regular use of commercial sunbeds. Photodermatol Photoimmunol Photomed (2002) 1.81
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med (1984) 1.79
Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies. Clin Immunol (2001) 1.78
Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J Exp Med (1987) 1.76
Oral aspirin challenges in asthmatic patients: a study of plasma histamine. Clin Allergy (1976) 1.74
Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding. Nucleic Acids Res (1989) 1.72
Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72
Alternative medicine in allergies - prevalence, patterns of use, and costs. Allergy (2002) 1.72
Studies of the binding of Escherichia coli RNA polymerase to DNA. V. T7 RNA chain initiation by enzyme-DNA complexes. J Mol Biol (1972) 1.70
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66
Epitopes, structural domains, and asymmetry of amino acid residues in SS-B/La nuclear protein. J Immunol (1986) 1.63
Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med (1991) 1.63
Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest (1989) 1.61
Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest (1989) 1.59
Congenital leukonychia totalis in two brothers. Acta Derm Venereol (1998) 1.58
Identification of ribosomal protein autoantigens. J Immunol (1985) 1.57
Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies. J Epidemiol Community Health (2008) 1.56
General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy (2002) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol (2001) 1.54
Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum (1988) 1.54
Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp Cell Res (1990) 1.53
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum (1997) 1.53
Monoclonal anti-histone autoantibodies derived from murine models of lupus. J Immunol (1984) 1.52
Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med (1996) 1.52
Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? Clin Exp Allergy (2011) 1.51
Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy (2008) 1.50
IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. J Immunol (1986) 1.50
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol (2001) 1.49
Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol (1986) 1.49
Ultraviolet light alteration of cellular deoxyribonucleic acid in vivo. Proc Natl Acad Sci U S A (1969) 1.48
Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med (1979) 1.44
Studies on antibodies to histones by immunofluorescence. Scand J Immunol (1976) 1.43